Portal de investigação
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Citar a publicação
Kobayashi M,Girerd N,Ferreira JP,Kevin D,Huttin O,Gonzalez A,Bozec E,Clark AL,Cosmi F,Cuthbert J,Diez J,Edelmann F,Hazebroek M,Heymans S,Mariottoni B,Pellicori P,Petutschnigg J,Pieske B,Staessen JA,Verdonschot J,Rossignol P,Cleland JGF,Zannad F. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial. Eur. J. Heart Fail. 2022. 24. (9):p. 1559-1568. IF:18,200. (1).
